What is Agios Pharmaceuticals's earnings yield?

Agios Pharmaceuticals (AGIO) reported earnings yield of -21.3% in Q1 2026.

What is the long-term trend for Agios Pharmaceuticals's earnings yield?

Over 3 years (2020 to 2025), Agios Pharmaceuticals's earnings yield has grown at a 23.2% compound annual growth rate (CAGR), from -13.9% to -26%.

What does earnings yield mean?

Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.

Agios Pharmaceuticals AGIO Earnings yield

Earnings yield at other companies

Bristol-Myers SquibbBMY

5.9%+1.6pp

PfizerPFE

6.8%—

Vertex PharmaceuticalsVRTX

3.8%—

IncyteINCY

7.6%+7.5pp

BioMarin PharmaceuticalsBMRN

5%+2.6pp

Disc MedicineIRON

-9.9%+8.4pp

Other financials

Income statement

See full

Revenue$20.7M+138%

Gross profit$19.4M+154%

Operating income-$110.0M-3.2%

Net income-$99.1M-11.0%

EPS (diluted)-$1.69-9.0%

Balance sheet

See full

Cash & equivalents$113.6M+43.9%

Total debt$35.7M-32.5%

Total equity$1.1B-24.4%

Total assets$1.2B-23.8%

Cash flow

See full

Operating cash flow-$118.9M-6.7%

CapEx$769.0K+0.4%

Free cash flow-$119.7M-6.6%

Valuation

See full

Market cap$2.12B+18.1%

Enterprise value$2.04B+15.2%

P/S32.1×-16.4×

Profitability

See full

Gross margin90%+2.5pp

Operating margin-720%-204pp

Net margin-639.8%—

FCF margin-582.5%-185pp

Returns & leverage

See full

Return on equity-32.8%—

Debt / equity0×0.0×

Current ratio14.2×-4.3×

Where this comes from

Calculated from Agios Pharmaceuticals’s reported figures.

net income/market cap=-21.3%

Based on trailing twelve months.

The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agios Pharmaceuticals's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Agios Pharmaceuticals's earnings yield?: Agios Pharmaceuticals (AGIO) reported earnings yield of -21.3% in Q1 2026.
What is the long-term trend for Agios Pharmaceuticals's earnings yield?: Over 3 years (2020 to 2025), Agios Pharmaceuticals's earnings yield has grown at a 23.2% compound annual growth rate (CAGR), from -13.9% to -26%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.